Charleston Oncology | Charleston, NC

Research site
2085 Henry Tecklenburg Drive, 2nd Floor, Charleston, South Carolina, United States of America
Site insights

Top conditions

Breast Cancer (4 trials)

Lung Cancer (3 trials)

Triple Negative Breast Cancer (2 trials)

Multiple Myeloma (2 trials)

Non-Small-Cell Lung Carcinoma (2 trials)

Top treatments


Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


9 of 18
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer (FRESCO-2)

This is a global, randomized, double-blind, placebo-controlled, multicenter phase 3 clinical trial to compare the efficacy and safety of fruquintinib...

Active, not recruiting
Metastatic Colorectal Cancer
Metastatic Colon Cancer
Drug: Fruquintinib
Drug: Placebo

This study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast ca...

HER2 Positive Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Participants in this study will have diffuse large B-cell lymphoma (DLBCL) that has come back or not gotten better with treatment. The trial will stu...

Active, not recruiting
Diffuse Large B-cell Lymphoma
Drug: Brentuximab vedotin
Drug: Lenalidomide

The purpose of this study is to evaluate the antitumor effects of sotorasib and RMC-4630 in subjects with KRASG12C mutant NSCLC

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: RMC-4630
Drug: Sotorasib

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tum...

Drug: Temozolomide
Drug: Capecitabine

The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with nab-paclitax...

Active, not recruiting
Triple-Negative Breast Cancer
Drug: Sacituzumab Govitecan-hziy
Drug: Magrolimab

The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with docetaxel in...

Active, not recruiting
Solid Tumor
Drug: Magrolimab
Drug: Docetaxel

A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation

Active, not recruiting
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
Drug: Docetaxel
Drug: AMG 510

The aim of this study is to provide darolutamide treatment to patients who participated in a previous study with darolutamide supported by Bayer and...

Drug: Darolutamide (Nubeqa, BAY1841788)

Trial sponsors

Amgen logo

Amgen (2 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems